Santersus AG Completes Series A Financing led by Norcliffe Capital, joined by Terumo Ventures, and Announces Strategic Collaboration with Terumo Corporation and Advancement of NucleoCapture into Pivotal Clinical Development
Zurich, Switzerland – December 1, 2025 – Santersus AG today announced the successful completion of its Series A financing, led by Norcliffe, a UK life sciences fund with participation from Terumo Ventures. The financing will support the advancement of Santersus’ NucleoCapture™ into pivotal clinical development while accelerating progress across Santersus’ broader pipeline. Santersus has entered …